RELAPSED ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed leukemia: experimental drug combo enters safety trial
Disease control Recruiting nowThis early-stage study tests whether adding a new drug called revumenib to two standard chemotherapy drugs is safe for children and young adults whose acute myeloid leukemia (AML) has not responded to treatment or has returned. The study involves 24 participants and aims to find …
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 16, 2026 20:35 UTC
-
New hope for relapsed leukemia: IMAGINE trial tests Triple-Drug combo
Disease control Recruiting nowThis early-phase trial is for adults with acute myeloid leukemia (AML) that has come back or not responded to prior treatment. It tests a new drug called imetelstat combined with standard chemotherapy drugs (azacitidine with or without venetoclax) to find the safest and most effe…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New combo aims to control tough AML cases
Disease control Recruiting nowThis study tests a combination of three drugs (tagraxofusp, cladribine, and cytarabine) in 20 adults with CD123-positive acute myeloid leukemia (AML) that has come back or not responded to prior treatment. The goal is to find the best dose and see if the combo can help achieve re…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New CAR t cell therapy targets Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new treatment called CD371-YSNVZ-IL18 CAR T cells for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The main goal is to find the safest dose and see what side effects occur. About 15 participants w…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New combo therapy aims to boost leukemia remission
Disease control Recruiting nowThis study tests adding venetoclax to a standard chemotherapy regimen (CLAG-M) for people with acute myeloid leukemia (AML) or related high-grade blood cancers. The goal is to find the safest dose and see if the combination improves how long patients stay cancer-free. About 62 ad…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC